Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like break out to the DOWNSIDE has started!!
Time to sell this SCAM!!!
LMFAO!!! Exactly! Lets go $VDRM $$$$$
$ land coming this year!!
Link??
Agreed!..and almost NIL short volume!!
$VDRM $$$
More like 100,000.. lol
Lets go $VDRM $$$$$$$$
ViaDerma Inc., Provides Review of 2020 and Looks Forward to 2021Press Release | 01/13/2021
LOS ANGELES, Jan. 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), President and CEO, Dr. Christopher Otiko offers a review of 2020 and provides a summary of his expectations for the coming year 2021.
“Despite the challenges faced by many companies, including ViaDerma during 2020, our Company has been able to make very significant strides forward that have laid the foundation for what we believe could be a record-breaking year,” said Dr. Christopher Otiko, President of ViaDerma.
Some of the highlights of the past 12 months include:
The FDA approved the registration of a new 55 ml Vitastem spray bottle. This came at the request of hospitals that have tested the product. A larger spray version will be easier to apply the medication to large wounds.
Liberdol, a new relief pain product was officially launched in 2020. The analgesics market in the U.S. is estimated to be more than $12 billion dollars.
An extended line of credit was secured for financing future manufacturing. We anticipate sales to top 500,000 units in 2021.
A large national hospital chain and a major health insurance company have completed successful testing of the Vitastem product. We are now in the final stages of discussions to determine the size of the initial purchase.
Successful product testing was completed by a major midwestern university with whom we are also in discussions regarding their initial product purchase.
We have initiated discussions with a major global medical nonprofit that has expressed interest in purchasing Vitastem for use by their doctors and medical staff in treating patients.
About ViaDerma, Inc.
ViaDerma, Inc. (OTC: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. For more information, visit: www.viadermalicensing.com
Any forecast of future performance is a "forward looking statement" under securities laws. Such statements are included to allow potential investors the opportunity to understand management’s beliefs and opinions with respect to the future so that they may use such beliefs and opinions as one factor among many in evaluating an investment.
Contact information:
Investor Relations
Email: info@viadermalicensing.com
Phone: 310-374-6111
https://www.otcmarkets.com/stock/VDRM/news/ViaDerma-Inc-Provides-Review-of-2020-and-Looks-Forward-to-2021?id=286028
VDRM BIG NEWS OUT.Dr. Otiko added, “This is the first of several important milestones we expect to achieve in the coming months.”
https://www.globenewswire.com/news-release/2021/01/21/2161920/0/en/ViaDerma-Inc-Completes-a-Licensing-Agreement-with-a-Group-of-Affiliate-Wound-Care-Medical-Practices-Operating-in-Six-States.html
ViaDerma, Inc. Completes a Licensing Agreement with a Group of Affiliate Wound Care Medical Practices Operating in Six States
Email Print Friendly Share
January 21, 2021 05:00 ET | Source: ViaDerma, Inc.
LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announces the completion of a licensing agreement with a group of affiliated wound care medical practices. The medical practices provide advanced wound care treatment to homebound patients and are currently operating in six states. ViaDerma’s goal is to increase its presence to medical practices in sixteen states this year and to be in all fifty states by the end of 2022.
As part of their wound care treatment protocol, the medical practices will be utilizing their own private label medication based on the technology developed by ViaDerma President and CEO, Dr. Chris Otiko. The cost of the licensing agreement is $5000 per practice per month. The current agreement is worth $30,000 per month ($360,000 annually). The first payment of $30,000 is due before the end of January 2021.
“We are incredibly pleased to have finalized this licensing agreement as we begin the new year. One of our main objectives is to continue expanding our licensing model to include a greater number of medical practices and increase the recurring monthly revenues for ViaDerma,” said Dr. Chris Otiko, ViaDerma President and CEO.
Dr. Otiko added, “This is the first of several important milestones we expect to achieve in the coming months.”
About ViaDerma, Inc.
ViaDerma, Inc. (OTC: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. For more information, visit: www.viadermalicensing.com
Any forecast of future performance is a "forward looking statement" under securities laws. Such statements are included to allow potential investors the opportunity to understand management’s beliefs and opinions with respect to the future so that they may use such beliefs and opinions as one factor among many in evaluating an investment.
Contact information:
Investor Relations
Email: info@viadermalicensing.com
Phone:
310-374-6111
WOW!! https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm
Select labeler and type in Viaderma
100% AGREED!!!! Lets go $VDRM $$$$$$$
The next new release will explode humongous
CEO said 500000 units sales anticipation which is around $80 million dollars
RECORD BREAKING YEAR as per CEO
Learn how to read a chart 'bank director' BAHAHAHAHA
Give it a rest already
Agreed Volcano! Just a matter of time... its accumulation time!
$VDRM $$$$
It is based on anticipated revenue this year
This is just starting now
If you can wait for this year and the company can attain the anticipated revenue potential
It is market price for pharmaceutical company making $80 million
I think hospital and medical group will use new version 55ml Vitastem most likely
Even 40 mil revenue is good enough for $10 price target this year
CEO said RECORD BREAKING YEAR
10000% run in the making
Be patient
ACCUMULATE ACCUMULATE ACCUMULATE !! Wait for next news release!
Lets go $VDRM $$$$$
Agreed! .025+ close coming! Slow march to $$$ land!!
$VDRM $$$
100%!!! Just getting started!! Explosion to dollar land coming soon! $VDRM $$$$$$
Warming up for huge explosion
Large national hospital chain contract news imminent
Super volcanic explosion
Next news release will put us over .10+.. just keep accumulating down here!! EASY $$$$$
$VDRM $$$$$
Not sure if your numbers are correct but it sounds pretty impressive!!
Even $1 would be an EPIC RISE!!!!
$VDRM $$$$$$
I think its shorts still covering IMO
Its going to pop sooner or later!
$VDRM
Come on PAUL.. get off the ASK!!!
Lets go $VDRM
Lets see a GREEN close!
Nice! Welcome to the clan!
Agreed! This should close green today.. watch it move up into the close! I have a hunch news will be early February. 2021 is VDRM's year!!
Lets go!!!!!
$VDRM $$$$
Try more like .25!! It’s coming ;)
$VDRM $$$
Up she goes! This should have a steady climb back up!! This is where you make $ ;)
A long time awaited 55ml Vitastem spray’s approval from FDA finally occurred. The company can distribute the spray to multiple hospitals, clinics, and drug stores to provide a soliton for large injuries.
As the analgesics market in the U.S is almost $12 billion dollars offering new Liberdol for pain relief purposes has opened a bright opportunity to diversify the revenue soon.
The management anticipates 500 000 units of sales in 2021
https://ownsnap.com/by-over-14-fold-soaring-viaderma-vdrm-has-serious-ambitions-in-drug-manufacturing/
$VRDM
Looks like we could close above .03 ... $VDRM $$$
Looks like shorts are almost done! Moving back up...
Only DUMMIES selling here!! LMFAO!! Oh will they regret it!
$VDRM $$$$$$
That's a pretty good day trading strategy tbh.. but with the right news, it will only keep going up .. time will tell my friend
It won't matter when the next news hits.. we'll be well over .10+
You'll be saying the same thing when $VDRM is over .10.. 2021 is VDRM's year!! FINALLY it is HAPPENING!!
$$$$$$$$$$$$$$$
People selling here are going to really regret it soon!
$VDRM $$$
I Agree! Lots of BIG BUYS pouring in.. we should close above 4 cents today!! $VDRM